IFM Investors Pty Ltd Has $14.14 Million Position in HCA Healthcare, Inc. (NYSE:HCA)

IFM Investors Pty Ltd grew its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 10.2% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 40,933 shares of the company's stock after purchasing an additional 3,781 shares during the period. IFM Investors Pty Ltd's holdings in HCA Healthcare were worth $14,144,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Atwood & Palmer Inc. acquired a new position in shares of HCA Healthcare in the first quarter worth about $28,000. Bartlett & CO. Wealth Management LLC boosted its holdings in shares of HCA Healthcare by 888.9% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock worth $31,000 after buying an additional 80 shares during the period. ORG Partners LLC boosted its holdings in shares of HCA Healthcare by 344.0% in the first quarter. ORG Partners LLC now owns 111 shares of the company's stock worth $38,000 after buying an additional 86 shares during the period. Tidemark LLC acquired a new stake in shares of HCA Healthcare during the fourth quarter worth approximately $36,000. Finally, Legacy Investment Solutions LLC boosted its holdings in shares of HCA Healthcare by 99.0% during the fourth quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock worth $62,000 after purchasing an additional 95 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the sale, the chief operating officer owned 12,646 shares in the company, valued at $4,670,420.72. The trade was a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.30% of the stock is owned by corporate insiders.

HCA Healthcare Stock Performance

Shares of NYSE:HCA traded up $1.93 during trading on Monday, reaching $378.51. The stock had a trading volume of 1,369,708 shares, compared to its average volume of 1,463,071. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The firm has a market capitalization of $91.06 billion, a price-to-earnings ratio of 16.83, a P/E/G ratio of 1.30 and a beta of 1.47. The company has a quick ratio of 1.06, a current ratio of 1.19 and a debt-to-equity ratio of 69.07. The stock has a fifty day simple moving average of $372.47 and a two-hundred day simple moving average of $340.19.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.75 by $0.70. The business had revenue of $18.32 billion for the quarter, compared to the consensus estimate of $18.26 billion. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. HCA Healthcare's quarterly revenue was up 5.7% on a year-over-year basis. During the same quarter last year, the company posted $5.36 earnings per share. As a group, analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 30th. Stockholders of record on Monday, June 16th were paid a $0.72 dividend. The ex-dividend date was Monday, June 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.76%. HCA Healthcare's payout ratio is 12.81%.

Analysts Set New Price Targets

Several research firms recently commented on HCA. Royal Bank Of Canada restated an "outperform" rating and set a $404.00 price target (up from $376.00) on shares of HCA Healthcare in a report on Monday, June 23rd. Morgan Stanley set a $410.00 price target on shares of HCA Healthcare and gave the stock an "equal weight" rating in a report on Monday, June 9th. Barclays set a $416.00 price target on shares of HCA Healthcare and gave the stock an "overweight" rating in a report on Monday, June 2nd. Wall Street Zen raised shares of HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday. Finally, Stephens raised shares of HCA Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Seven equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $395.71.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.